Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

NCT01395550 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01395550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01395550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2010
Enrollment
88 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular events